Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

Detalles Bibliográficos
Autores principales: Swords, R T, Watts, J, Erba, H P, Altman, J K, Maris, M, Anwer, F, Hua, Z, Stein, H, Faessel, H, Sedarati, F, Dezube, B J, Giles, F J, Medeiros, B C, DeAngelo, D J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386335/
https://www.ncbi.nlm.nih.gov/pubmed/28157218
http://dx.doi.org/10.1038/bcj.2017.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386335/
https://www.ncbi.nlm.nih.gov/pubmed/28157218
http://dx.doi.org/10.1038/bcj.2017.1

Ejemplares similares